These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 2476460)

  • 21. Antigenicity of linear B-cell epitopes in the C1, V1, and V3 region of HIV-1 gp 120.
    van Tijn DA; Boucher CA; Bakker M; Goudsmit J
    J Acquir Immune Defic Syndr (1988); 1989; 2(3):303-6. PubMed ID: 2470894
    [No Abstract]   [Full Text] [Related]  

  • 22. Synthetic peptides and anti-peptide antibodies as probes to study interdomain interactions involved in virus assembly: the envelope of the human immunodeficiency virus (HIV-1).
    Neurath AR; Strick N; Jiang S
    Virology; 1992 May; 188(1):1-13. PubMed ID: 1373549
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterization of a novel human immunodeficiency virus type 1 neutralizable epitope within the immunodominant region of gp41.
    Viveros M; Dickey C; Cotropia JP; Gevorkian G; Larralde C; Broliden K; Levi M; Burgess A; Cao C; Weiner DB; Agadjanyan MG; Ugen KE
    Virology; 2000 Apr; 270(1):135-45. PubMed ID: 10772986
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synthetic env gp41 peptide as a sensitive and specific diagnostic reagent in different stages of human immunodeficiency virus type 1 infection.
    Närvänen A; Korkolainen M; Suni J; Korpela J; Kontio S; Partanen P; Vaheri A; Huhtala ML
    J Med Virol; 1988 Oct; 26(2):111-8. PubMed ID: 2460585
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Oligomeric structure of gp41, the transmembrane protein of human immunodeficiency virus type 1.
    Pinter A; Honnen WJ; Tilley SA; Bona C; Zaghouani H; Gorny MK; Zolla-Pazner S
    J Virol; 1989 Jun; 63(6):2674-9. PubMed ID: 2786089
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Design of immunogens that present the crown of the HIV-1 V3 loop in a conformation competent to generate 447-52D-like antibodies.
    Chakraborty K; Durani V; Miranda ER; Citron M; Liang X; Schleif W; Joyce JG; Varadarajan R
    Biochem J; 2006 Nov; 399(3):483-91. PubMed ID: 16827663
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparing modified and plain peptide linked enzyme immunosorbent assay (ELISA) for detection of human immunodeficiency virus type-1 (HIV-1) and type-2 (HIV-2) antibodies.
    Manocha M; Chitralekha KT; Thakar M; Shashikiran D; Paranjape RS; Rao DN
    Immunol Lett; 2003 Feb; 85(3):275-8. PubMed ID: 12663143
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antibody recognition of synthetic peptides mimicking immunodominant regions of HIV-1 p24 and p17 proteins.
    Lottersberger J; Salvetti JL; Beltramini LM; Tonarelli G
    Rev Argent Microbiol; 2004; 36(4):151-7. PubMed ID: 15786866
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Production and characterization of a human monoclonal antibody, reactive with a conserved epitope on gp41 of human immunodeficiency virus type I.
    Teeuwsen VJ; Siebelink KH; Crush-Stanton S; Swerdlow B; Schalken JJ; Goudsmit J; van de Akker R; Stukart MJ; Uytdehaag FG; Osterhaus AD
    AIDS Res Hum Retroviruses; 1990 Mar; 6(3):381-92. PubMed ID: 1692724
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Two immunodominant domains of gp41 bind antibodies which enhance human immunodeficiency virus type 1 infection in vitro.
    Robinson WE; Gorny MK; Xu JY; Mitchell WM; Zolla-Pazner S
    J Virol; 1991 Aug; 65(8):4169-76. PubMed ID: 2072448
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sensitivity and specificity of anti-HIV ELISA employing recombinant (p24, p66, gp120) and synthetic (gp41) viral antigenic peptides.
    Filice G; Soldini L; Orsolini P; Razzini E; Gulminetti R; Campisi D; Chiapparoli L; Cattaneo E; Achilli G
    Microbiologica; 1991 Jul; 14(3):185-94. PubMed ID: 1717811
    [TBL] [Abstract][Full Text] [Related]  

  • 32. IgG subclass responses to a transmembrane protein (gp41) peptide in HIV infection.
    Chiodi F; Mathiesen T; Albert J; Parks E; Norrby E; Wahren B
    J Immunol; 1989 Jun; 142(11):3809-14. PubMed ID: 2497181
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Broadly neutralizing antibodies elicited by the hypervariable neutralizing determinant of HIV-1.
    Javaherian K; Langlois AJ; LaRosa GJ; Profy AT; Bolognesi DP; Herlihy WC; Putney SD; Matthews TJ
    Science; 1990 Dec; 250(4987):1590-3. PubMed ID: 1703322
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Definition of an immunodominant T cell epitope contained in the envelope gp41 sequence of HIV-1.
    Bell SJ; Cooper DA; Kemp BE; Doherty RR; Penny R
    Clin Exp Immunol; 1992 Jan; 87(1):37-45. PubMed ID: 1370773
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Envelope sequence variability and serologic characterization of HIV type 1 group O isolates from equatorial guinea.
    Hunt JC; Golden AM; Lund JK; Gürtler LG; Zekeng L; Obiang J; Kaptué L; Hampl H; Vallari A; Devare SG
    AIDS Res Hum Retroviruses; 1997 Aug; 13(12):995-1005. PubMed ID: 9264286
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antibody responses to HIV-1 envelope and gag epitopes in HIV-1 seroconverters with rapid versus slow disease progression.
    Zwart G; van der Hoek L; Valk M; Cornelissen MT; Baan E; Dekker J; Koot M; Kuiken CL; Goudsmit J
    Virology; 1994 Jun; 201(2):285-93. PubMed ID: 7514319
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Confronting the hypervariability of an immunodominant epitope eliciting virus neutralizing antibodies from the envelope glycoprotein of the human immunodeficiency virus type 1 (HIV-1).
    Neurath AR; Strick N
    Mol Immunol; 1990 Jun; 27(6):539-49. PubMed ID: 1696353
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The immunodominance of epitopes within the transmembrane protein (gp41) of human immunodeficiency virus type 1 may be determined by the host's previous exposure to similar epitopes on unrelated antigens.
    Davis D; Chaudhri B; Stephens DM; Carne CA; Willers C; Lachmann PJ
    J Gen Virol; 1990 Sep; 71 ( Pt 9)():1975-83. PubMed ID: 2170568
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inactivation of a common epitope responsible for the induction of antibody-dependent enhancement of HIV.
    Mitchell WM; Ding L; Gabriel J
    AIDS; 1998 Jan; 12(2):147-56. PubMed ID: 9468363
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Detection of antibodies to human immunodeficiency virus type I by using synthetic peptides and time-resolved fluoroimmunoassay (TR-FIA).
    Lombardi VR; Libonatti O; Alimandi M; Ansotegui I; Scarlatti G; Moschese V; Wigzell H; Rossi P
    Eur J Epidemiol; 1992 Mar; 8(2):298-304. PubMed ID: 1644152
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.